Skip to content
Tactile Systems Technology logo

Tactile Systems Technology

TCMD

Tactile Systems Technology, Inc., doing business as Tactile Medical, is a medical technology company specializing in at-home therapies for underserved chronic diseases.

Market cap
$626.16M+165%
Revenue$343.5M+17.2%
Net income$20.3M+25.3%
Free cash flow$39.2M+3.6%
EPS (diluted)$0.88+33.3%
Trailing twelve months · change vs. prior year

Earnings

Next report

Aug 10, 2026 (In 1 week)
Revenue estimate$85.5M
EPS estimate$0.14

Financials

Q1 2026

Income statement

See full
Revenue$75.3M+22.8%
Gross profit$57.6M+27.1%
Operating income-$1.5M+66.2%
Net income-$1.8M+40.7%
EPS (diluted)-$0.08+38.5%

Balance sheet

See full
Cash & equivalents$75.0M-10.3%
Total debt$15.2M-62.7%
Total equity$217.9M+5.9%
Total assets$272.1M-2.9%

Cash flow

See full
Operating cash flow-$339.0K-181%
CapEx$821.0K+117%
Free cash flow-$1.2M-3,153%

Valuation & ratios

Valuation

See full
Market cap$626.16M+165%
Enterprise value$566.34M+180%
P/E30.9×+14.7×
P/S1.8×+1.0×

Profitability

See full
Gross margin76.4%+1.8pp
Operating margin9.4%+2.4pp
Net margin5.9%+0.4pp
FCF margin11.4%-1.5pp

Returns & leverage

See full
Return on equity9.6%+1.5pp
Debt / equity0.1×-0.1×
Current ratio4.2×-0.3×

Segments

By product

See full
Lymphedema Products$62.2M+23.1%
Airway Clearance Products$13.0M+21.8%

Competitors

Profile

Tactile Systems Technology, Inc., doing business as Tactile Medical, is a medical technology company specializing in at-home therapies for underserved chronic diseases. The company develops and provides clinically proven medical devices that treat vascular disorders, oncology-related complications, and chronic respiratory conditions. Its core value proposition centers on improving patient outcomes and quality of life while reducing rising healthcare expenditures through a scalable home-care delivery model.

Competitive position

Tactile Medical is a leading provider of at-home compression therapy, holding a significant competitive advantage through its extensive reimbursement infrastructure and proprietary pneumatic compression technology.

GeographiesUnited States
Customer segmentsChronic disease patients, Healthcare providers, Durable medical equipment retailers
Business modelDirect-to-consumer, B2B distribution, Medical device manufacturing
SuppliersMedical component manufacturers, Software developers for mobile applications, Regulatory bodies (FDA)
CustomersDurable Medical Equipment (DME) providers, Hospitals and clinics, Individual patients, Veterans Administration
Listed2016
Employees992.0
CEOSheri Louise Dodd
FilingsSEC EDGAR

Questions, answered.

What is Tactile Systems Technology's market cap?
Tactile Systems Technology (TCMD) has a market capitalization of $626.2M and trades on NASDAQ.
What is Tactile Systems Technology's revenue and profitability?
Tactile Systems Technology generated $343.5M in trailing twelve-month revenue with net income of $20.3M, representing a net margin of 5.9%. Gross margin stands at 76.4%, with free cash flow of $39.2M. These figures are based on the Q1 2026 filing.
Who are Tactile Systems Technology's competitors?
Tactile Systems Technology's key competitors include InfuSystem Holdings, Inc., AngioDynamics, Inc., Merit Medical Systems Inc, and others. These companies compete in similar markets and product categories.
Where is Tactile Systems Technology headquartered?
Tactile Systems Technology is headquartered in United States of America and employs approximately 992 people. It has been publicly traded since 2016.